MOS — The Mosaic Company — is one of the world's largest producers of phosphate and potash crop nutrients. After a steep 2026 selloff driven by a sulfur cost shock and idled phosphate capacity, the shares trade near multi-year lows. The central question for investors is whether the stock can climb back toward the $26 average analyst price target.
Analyst coverage of Mosaic is heavily divided. Recent actions include an RBC Capital downgrade to Sector Perform with a target cut to $25 from $27, Mizuho trimming to $22 from $25 while staying Neutral, and Barclays cutting to $22 from $26 at an Equal Weight rating. On the cautious side, J.P. Morgan holds a Sell with a $19 target, and Freedom Broker downgraded to Sell at $17. More constructive voices remain: BMO Capital reiterates Buy at $30, Goldman Sachs keeps a Buy at $28, and Bank of America, Morgan Stanley, and KeyBanc are clustered near $26.
Across approximately 20 analysts, the targets span roughly $17 to $35, and the calculated average works out to about $26.30, rounded to a central target of $26. The wide range reflects a genuine split between analysts who see a multi-year phosphate recovery and those who expect margin pressure and weak cash generation to persist through 2027.
Mosaic shares closed near $17.68 on October 21, 2026, just above a fresh 52-week low around $18.36. Reaching the $26 average analyst price target would require a gain of roughly 47% — a very large move by any measure. That magnitude matters because it signals the market is currently pricing a meaningful probability that the company's earnings trough lasts longer than bulls anticipate.
The path toward $26 would likely require a visible recovery in phosphate economics. Mosaic withdrew its 2026 phosphate production guidance in May and began idling capacity in Louisiana, Florida, and Brazil after sulfur prices surged on Middle East shipping disruptions. In the quarter ended June 30, 2026, the company posted a $273 million net loss, with the phosphate segment alone reporting a $104 million operating loss and gross margin compressed to roughly 7.6%.
The stock is in a clear short-term downtrend, trading below both its 50-day and 200-day moving averages, which sit near $23. Durable resistance is evident around the $20 mark, with additional overhead near $23. On the downside, support has emerged near $18, and a break below that level would put the $16 zone into focus. The 52-week range of roughly $18 to $37 underscores how far sentiment has deteriorated, and a sustained move back above $20 would be a meaningful early signal that the selling pressure is easing.
Most analyst price targets reflect a roughly 12-month horizon, though the wide $17-to-$35 range shows meaningful differences in how long individual firms expect the phosphate recovery to take. The next key catalyst is the company's third-quarter 2026 results, scheduled for early November, which should clarify the severity of the sulfur cost impact and the pace of capacity restarts. Investors should also monitor global sulfur and phosphate pricing, any developments on Belarusian potash supply, S&P's rating outlook, and further analyst target revisions — several firms have already trimmed forecasts in response to the cost shock.
For traders looking to track a fast-moving, news-sensitive name like Mosaic, AI Daily Buy/Sell Signals from Tickeron offers a data-driven way to monitor changing conditions. The system uses artificial intelligence to continuously scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical behavior, and AI-driven analysis. It can help investors spot emerging opportunities, monitor existing positions, and identify trend shifts more efficiently than manual review. Explore the tool to see how AI can support your own market monitoring.
The $26 central target reflects the average of a wide and divided analyst range, not a consensus guarantee. Reaching it from around $17.70 would require a roughly 47% advance — a very large move that hinges on a genuine recovery in phosphate margins, a retreat in sulfur costs, and a restoration of cash generation. Supportive factors include a deeply depressed valuation, a high dividend yield, and the cyclical potential for input-cost normalization, while the principal obstacles are a still-rising cost shock, prolonged curtailments, negative free cash flow, and the threat of new low-cost potash supply. Whether MOS reaches $26 will depend on data rather than narrative, and the third-quarter earnings report is the next clear checkpoint.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MOS has been loosely correlated with NTR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MOS jumps, then NTR could also see price increases.